Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers

Fig. 1

Survival analysis of CD68 and CD163 expression based on estrogen receptor (ER) status. Kaplan–Meier curves of CD68 (upper panel) in ER-positive (a) and ER-negative (b) cases of cohort A and triple-negative breast cancer (TNBC) cohort B (c). Kaplan–Meier curves of CD163 (lower panel) in ER-positive (d) and ER-negative (e) cases of cohort A and TNBC cohort B (f)

Back to article page